List of likely buyers of Novartis’ Dermatology division ($2bn) takes shape

cafead

Administrator
Staff member
  • cafead   May 14, 2018 at 09:52: AM
via A list of likely buyers of Novartis’ US dermatology generics division, valued at an approximate $2bn, is now drawn up, Bloomberg has reported.

article source